Health ❯ Healthcare

Autoimmune Diseases

Lupus Rheumatoid Arthritis Systemic Lupus Erythematosus Research Psoriasis Type 1 Diabetes Multiple Sclerosis Dermatomyositis Treatment Strategies Stiff-Person Syndrome

Kissei Tells Japan Doctors to Halt New Tavneos Use After 20 Deaths Reported

The move signals growing global pressure on Amgen’s vasculitis drug during widening safety and data reviews.

UCB to Buy Candid Therapeutics for Up to $2.2 Billion

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

CAR-T Therapy Puts Three Autoimmune Diseases Into Sustained Remission in One Patient

Butantan Strikes Deal to Make CAR-T in Brazil as New Case Points to Wider Uses

Single CAR-T Infusion Puts Three Severe Autoimmune Diseases in Remission

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

NEJM Publication Confirms Phase 3 Win for Brepocitinib in Dermatomyositis

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

MHRA Approves Leqselvi for Severe Alopecia Areata in Adults

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

YSRCP Renews Push for TTD Chief B.R. Naidu to Quit After Viral Videos

FDA Grants Breakthrough Therapy Designation to Biogen’s Litifilimab for Cutaneous Lupus

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

FDA Grants Priority Review to Vera's Atacicept for IgA Nephropathy

Zenas' Obexelimab Meets Phase 3 Goals in IgG4-Related Disease With 56% Flare Risk Cut

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer